The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health/Traumatic Brain Injury Research Program (PH/TBIRP) to support critical PH- and TBI-related research and development efforts to benefit Service members, Veterans, and other beneficiaries of the military health system. As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the Defense Health Agency, J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC). The CDMRP provides PH/TBIRP execution management support for DHP core research program areas, including the Joint Program Committee 6/ Combat Casualty Care Research Program (JPC-6/CCCRP). JPC-6/CCCRP provides strategic oversight for the PH/TBI funds associated with this funding Program Announcement. The Defense Health Agency is working in collaboration with the U.S. Department of Veterans Affairs (VA) and other Federal agencies on research efforts to improve the lives of Service members and Veterans affected by traumatic brain injury, posttraumatic stress disorder, and other mental health conditions.
The FY18 PH/TBIRP Program Announcement and General Application Instructions for the following award mechanism is posted on the Grants.gov website.
FY18 PHTBIRP Joint DoD and VA Long-term Impact of Military-relevant Brain Injury Consortium (LIMBIC) – Preproposal due October 8
- Independent investigators at all academic levels (or equivalent)
- Supports a consortium conducting a single large longitudinal study and supporting sub-studies to analyze a large TBI cohort to include Service member and Veterans.
- Applicants must be able to demonstrate the ability to enroll relevant cohorts, including military and Veteran populations, and follow them over time.
- Applicants must address the Required Research Elements outlined in the Program Announcement.
- Applications should describe a single large longitudinal cohort study and a minimum of four related sub-studies.
- All projects shall be limited to clinical and epidemiological research.
- Clinical trials are not supported.
- Coordinating Center and study sites must apply through a single application.
- Preproposal is required; application submission is by invitation only.
- Maximum allowable costs (direct and indirect) are $25M via the DoD.
- Up to an additional $5M per year for 5 years will be provided by the VA to VA sites, depending on availability of funds.
- Maximum period of performance is 5 years.
A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at https://eBRAP.org prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions available for electronic downloading from the Grants.gov website. The application package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at https://eBRAP.org. For more information about the PH/TBIRP or other CDMRP-administered programs, please visit the CDMRP website (http://cdmrp.army.mil).
Point of Contact:CDMRP Help Desk